Stratos Wealth Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,726	Closed	-$809K	–	1760
2018 Q3	$809K	Sell	4,726 -72	-2%	-$12.3K	0.04%	383
2018 Q2	$620K	Buy	4,798 +4,727	+6,658%	+$611K	0.03%	498
2018 Q1	$7K	Hold	71	–	–	﹤0.01%	2479
2017 Q4	$6K	Buy	+71	New	+$6K	﹤0.01%	2336